Q0ED31 (Q0ED31_9HIV1) Unreviewed, UniProtKB/TrEMBL
Last modified
May 29, 2013.
Version 58.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry infoCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry infoCustomize orderNames and origin
| Protein names | Recommended name: Envelope glycoprotein gp160 RuleBase RU004292 | ||
| Gene names |
| ||
| Organism | Human immunodeficiency virus 1 EMBL BAF31376.1 | ||
| Taxonomic identifier | 11676 [NCBI] | ||
| Taxonomic lineage | Viruses › Retro-transcribing viruses › Retroviridae › Orthoretrovirinae › Lentivirus › Primate lentivirus group | ||
| Virus host | Homo sapiens (Human) [TaxID: 9606] |
Protein attributes
| Sequence length | 857 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | The envelope glyprotein gp160 precursor down-modulates cell surface CD4 antigen by interacting with it in the endoplasmic reticulum and blocking its transport to the cell surface By similarity. SAAS SAAS000328 RuleBase RU004292 The gp120-gp41 heterodimer allows rapid transcytosis of the virus through CD4 negative cells such as simple epithelial monolayers of the intestinal, rectal and endocervical epithelial barriers. Both gp120 and gp41 specifically recognize glycosphingolipids galactosyl-ceramide (GalCer) or 3' sulfo-galactosyl-ceramide (GalS) present in the lipid rafts structures of epithelial cells. Binding to these alternative receptors allows the rapid transcytosis of the virus through the epithelial cells. This transcytotic vesicle-mediated transport of virions from the apical side to the basolateral side of the epithelial cells does not involve infection of the cells themselves By similarity. SAAS SAAS000328 |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Amino acid modifications | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Glycosylation | 87 | 1 | N-linked (GlcNAc...) PDB 3NGB | ||||||
| Glycosylation | 236 | 1 | N-linked (GlcNAc...) PDB 3NGB | ||||||
| Glycosylation | 243 | 1 | N-linked (GlcNAc...) PDB 3NGB | ||||||
| Glycosylation | 264 | 1 | N-linked (GlcNAc...) PDB 3NGB | ||||||
| Glycosylation | 278 | 1 | N-linked (GlcNAc...) PDB 3NGB | ||||||
| Glycosylation | 291 | 1 | N-linked (GlcNAc...) PDB 3NGB | ||||||
| Glycosylation | 297 | 1 | N-linked (GlcNAc...) PDB 3NGB | ||||||
| Glycosylation | 335 | 1 | N-linked (GlcNAc...) PDB 3NGB | ||||||
| Glycosylation | 386 | 1 | N-linked (GlcNAc...) PDB 3NGB | ||||||
| Glycosylation | 392 | 1 | N-linked (GlcNAc...) PDB 3NGB | ||||||
| Glycosylation | 442 | 1 | N-linked (GlcNAc...) PDB 3NGB | ||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Construction and characterization of HIV-1 CRF01_AE infectious molecular clones." Sakamoto Y., Takekawa N., Tatsumi M. Submitted (MAR-2006) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE. Strain: 93TH057 EMBL BAF31376.1. |
| [2] | "Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01." Zhou T., Georgiev I., Wu X., Yang Z.Y., Dai K., Finzi A., Kwon Y.D., Scheid J.F., Shi W., Xu L., Yang Y., Zhu J., Nussenzweig M.C., Sodroski J., Shapiro L., Nabel G.J., Mascola J.R., Kwong P.D. Science 329:811-817(2010) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.68 ANGSTROMS) OF 43-486, GLYCOSYLATION AT ASN-87; ASN-236; ASN-243; ASN-264; ASN-278; ASN-291; ASN-297; ASN-335; ASN-386; ASN-392 AND ASN-442. |
| [3] | "Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing." NISC Comparative Sequencing Program Wu X., Zhou T., Zhu J., Zhang B., Georgiev I., Wang C., Chen X., Longo N.S., Louder M., McKee K., O'Dell S., Perfetto S., Schmidt S.D., Shi W., Wu L., Yang Y., Yang Z.Y., Yang Z. Mascola J.R.Science 333:1593-1602(2011) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 43-486. |
| [4] | "Structure-based design, synthesis, and characterization of dual hotspot small-molecule HIV-1 entry inhibitors." LaLonde J.M., Kwon Y.D., Jones D.M., Sun A.W., Courter J.R., Soeta T., Kobayashi T., Princiotto A.M., Wu X., Schon A., Freire E., Kwong P.D., Mascola J.R., Sodroski J., Madani N., Smith A.B. J. Med. Chem. 55:4382-4396(2012) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 43-486. |
| [5] | "Antiviral activity and binding mode of next generation CD4-mimetics." Curreli F., Kwon Y.D., Zhang H, Kwong P.D., Debnath A.K. Submitted (FEB-2012) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.49 ANGSTROMS) OF 43-486. |
| [6] | "Crystal Structures of HIV-1 gp120 Envelope Glycoprotein in Complex with Small Molecule Inhibitors that Target the CD4-Binding Site." Kwon Y.D., LaLonde J.M., Yang Y., Elban M.A., Sugawara A., Courter J.R., Jones D.M., Smith 3rd A.B., Debnath A.K., Kwong P.D. Submitted (FEB-2012) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 43-486. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AB253424 Genomic DNA. Translation: BAF31367.1. AB253425 Genomic DNA. Translation: BAF31376.1. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SMR | Q0ED31. Positions 82-486, 499-584. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gene3D | 2.170.40.20. 2 hits. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| InterPro | IPR000777. HIV1_GP160. IPR000328. Retroviral_envelope_protein. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pfam | PF00516. GP120. 1 hit. PF00517. GP41. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SUPFAM | SSF56502. GP120. 1 hit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EvolutionaryTrace | Q0ED31. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | Q0ED31_9HIV1 | ||||||||
| Accession | Primary (citable) accession number: Q0ED31 | ||||||||
| Entry history |
| ||||||||
| Entry status | Unreviewed (UniProtKB/TrEMBL) | ||||||||

Clusters with